Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system
- PMID: 35909560
- PMCID: PMC9331276
- DOI: 10.3389/fendo.2022.960930
Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system
Keywords: aldosterone; diabetes mellitus; glucagon-like peptide-1 receptor agonists; growth hormone; parathyroid hormone; sodium-glucose cotransporter-2 inhibitors; testosterone; thyroid hormones.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Effects of Pharmacologic Therapy for Diabetes Mellitus on The Endocrine System.
References
-
- Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al. . 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care (2020) 43(2):487–93. doi: 10.2337/dci19-0066 - DOI - PMC - PubMed
-
- ajaj HS, Gerstein HC, Rao-Melacini P, Basile J, Colhoun H, Conget I, et al. . Erectile function in men with type 2 diabetes treated with dulaglutide: An exploratory analysis of the REWIND placebo-controlled randomised trial. Lancet Diabetes Endocrinol (2021) 9(8):484–90. doi: 10.1016/S2213-8587(21)00115-7 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
